J S Rasey

Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole.

T W Griffin, T K Lewellen, M. Graham, 1992, International journal of radiation oncology, biology, physics.

Binding of the hypoxia tracer [3H]misonidazole in cerebral ischemia.

John M. Hoffman, J M Hoffman, J. Hoffman, 1987, Stroke.

A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data.

M. Graham, J. Rasey, J. Casciari, 1995, Medical physics.

Radiolabeled hypoxic cell sensitizers: tracers for assessment of ischemia.

M J Welch, M R Kilbourn, M. Raichle, 1987, Life sciences.

Determination of the radiobiologically hypoxic fraction in multicellular spheroids from data on the uptake of [3H]fluoromisonidazole.

J S Rasey, J J Casciari, 1995, Radiation research.

Positron imaging feasibility studies. I: Characteristics of [3H]thymidine uptake in rodent and canine neoplasms: concise communication.

S M Larson, S. Larson, M. Graham, 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography.

K L Lindsley, T K Lewellen, M. Graham, 1995, International journal of radiation oncology, biology, physics.

Positron imaging feasibility studies: selective tumor concentration of 3H-thymidine, 3H-uridine, and 14C-2-deoxyglucose.

S M Larson, S. Larson, J. Rasey, 1980, Radiology.

Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells.

K. Krohn, J. Rasey, R E Durand, 1987, Radiation research.

Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients.

T K Lewellen, M. Graham, T. Lewellen, 1996, International journal of radiation oncology, biology, physics.